MD Healthcare Inc.

Minhye Kim

Yoon-Keun Kim

Young-Ju Kim

Young Koo Jee

Mina Rho

Byung-In Moon

Bok Yang Pyun

Jun-Pyo Choi

Provided is a composition for the treatment of pregnancy-associated diseases, and more particularly, to a pharmaceutical composition for the prevention or treatment of premature delivery or breast cancer. The pharmaceutical composition including extracellular vesicles derived from bacteria belonging to the genusas an active ingredient may induce pregnancy or prevent premature delivery of pregnant women, may be used to prevent or treat pregnancy-associated diseases such as breast cancer, and may be used to diagnose a risk of premature delivery by measuring the amount of extracellular vesicles derived from bacteria belonging to the genusin pregnant women.

Method for diagnosing premature delivery in a pregnant woman

Provided is a composition for preventing, ameliorating, or treating inflammatory diseases, the composition including, as active ingredients, lactic acid bacteria-derived extracellular vesicles isolated from culture fluid of lactic acid bacteria; and a method for diagnosing atopic dermatitis. The composition including the lactic acid bacteria-derived extracellular vesicles as active ingredients is expected to be usefully used in development of drugs, cosmetics, or health functional food for preventing, ameliorating, or treating inflammatory diseases such as atopic dermatitis, chronic rhinitis, chronic rhinosinusitis, asthma, chronic obstructive pulmonary disease, sepsis, etc. Also, the composition will be usefully used for diagnosis of atopic dermatitis by measuring the distribution of lactic acid bacteria-derived extracellular vesicles in a urine or blood sample.

Method of treating an inflammatory disease using lactic acid bacteria-derived extracellular vesicles

Growing community of inventors

Seoul, South Korea

Minhye Kim